Title for MeetingAbstracts

Alphabetical listing of titles

• Production of HIV-1 protein but not infectious virus in G1 arrested MT-2 cells.
• Production of HIV-1 Vaccine Components in Plants.
• Production of HIV/AIDS information in different languages.
• Production of human beta-chemokines in AIDS-Kaposi's sarcoma patients.
• Production of human bispecific monoclonal antibodies (bs-mAbs) that neutralize HIV-1.
• Production of human monoclonal antibodies against the V3 loop of gp120.
• Production of IL-8 by peripheral blood mononuclear cells in HIV-infected patients.
• Production of improved HIV CTL epitopes.
• Production of infectious virus by rabbit cells transfected with cloned HIV-1.
• Production of macrophage inflammatory proteins MIP-1[alpha], MIP-1[beta] and RANTES in HIV-1 infection from antigen-stimulated seminal cells and whole blood: correlation with Th1 type cytokine responses.
• Production of MN neutralizing monoclonal antibodies.
• Production of monoclonal and polyclonal antibodies specific to recombinant p24 antigen of HIV-1 subtype E and initial development of an in-house HIV-1 p24 antigen assay.
• Production of monoclonal antibodies to conserved sequences of the principal neutralizing determinant (PND) of HIV-1 gp120: in vitro/in vivo studies.
• Production of monokines in HIV-1 infected hemophiliacs.
• Production of monokines in peripheral blood mononuclear cells of the patients infected with human immunodeficiency virus.
• Production of neurotoxic mediators by PBMC from HIV-1 infected individuals during HAART.
• Production of nitric oxide in HIV-1 infected patients treated with IL-2.
• Production of non-infectious HIV particles in presence of HIV proteinase inhibitor.
• PRODUCTION OF RESISTANT HIV MUTANTS DURING ANTIRETROVIRAL THERAPY.
• Production of type-1, type-2 cytokines and beta-chemokines in HIV+ patients: influence of HAART.
• Production, Characterization, and Oligomeric Stabilization of Recombinant Disulfide Linked (SOS) HIV-1 Envelope Glycoproteins.
• Production, functional characterization and mapping of monoclonal antibodies to DC-SIGN.
• Production, local adaptation and implementation of practice guidelines using evidence-based approaches: the collaboration between Emilia Romagna Regional Agency and the Italian Cochrane Centre.
• Productive and latent HIV infection in peripheral blood and lymphoid tissue during antiretroviral therapy with or without interleukin-2.
• Productive and latent infection of human large granular lymphocytes by human T-cell leukemia virus-I.
• Productive and non-lytic HIV-1 replication in a newly established biphenotypic cell line derived from a patient with myelodysplastic syndrome.
• Productive and persistent infection of MT-4 cells with HIV-1 vif mutant.
• Productive HIV infection in double negative (DN) T cells obtained ex vivo.
• Productive HIV infection levels correlate with AIDS related manifestations in the patients.
• Productive HIV infection levels in the course of anti-viral therapies.